Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237210 · ClinicalTrials.gov registry record
7T MRS in Parkinson's Disease
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 78
- Enrollment target
NCT01237210 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 78 participants.
The verdict
NCT01237210 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
This study is looking for healthy controls and patients with Parkinson's (PD) to perform an MR scan. 1. The neurochemical profile of the SN of patients with PD as measured by high field MRS will differ from that of healthy controls, in that glutathione will be lower due to oxidative stress, lactate will be higher due to mitochondrial dysfunction, the gliosis markers myo-inositol and glutamine will be higher due to inflammation (glial activation) and N-acetylaspartate and glutamate will be lower due to neuronal loss/damage. 2. There will be a relationship between neurochemical changes and disease severity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-02 |
| Est. Completion | 2019-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237210
The ClinicalTrials.gov registry entry for NCT01237210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01237210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01237210 about?
NCT01237210 is a clinical study titled "7T MRS in Parkinson's Disease". This study is looking for healthy controls and patients with Parkinson's (PD) to perform an MR scan. 1. The neurochemical profile of the SN of patients with PD as measured by high field MRS will differ from that of healthy controls, in that glutathione will be lower due to oxidative stress, lactate...
What is the current status of trial NCT01237210?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2010-02. Estimated completion is 2019-02.
Who is sponsoring clinical trial NCT01237210?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.